StellarCube selected for the Korea Venture Business Association's Gangnam-gu Global Startup IR Support Program

StellarCube, a specialist in AI and healthcare, announced that it has been selected as a participating company in the 2026 Gangnam-gu Global Startup IR Support Program, for which the Korea Venture Business Association invited applications.

The program supports promising ventures and startups based in Gangnam-gu in strengthening their fundraising capabilities. Selected companies receive tailored IR consulting, production of IR materials in Korean and English, investor presentations and one-to-one meetings.

StellarCube plans to use the selection to accelerate the global fundraising strategy for PainCube, its AI-based pain management platform. PainCube quantifies a patient's pain state and predicts the likelihood of pain occurring in advance, using multimodal biosignals such as ECG (electrocardiogram), PPG (photoplethysmogram) and HRV (heart rate variability) together with EMR (electronic medical record) data. It is being developed with the particular aim of supporting pain assessment and analgesic dosing decisions for patients who have difficulty communicating, including intensive care patients, surgical patients and elderly patients.

StellarCube is securing clinical data and refining PainCube's AI models through joint research with Korea University Anam Hospital and Johns Hopkins University. It is also developing the platform into a hardware-free SaMD that can work with existing bedside monitoring equipment, so that it can be applied in clinical settings without dedicated hardware.

Through the Global Startup IR Support Program, StellarCube will refine PainCube's technology, market potential and global expansion strategy from an investor's perspective, and actively pursue opportunities for entry into the US medical market and follow-on investment.

Jinseob Noh, CEO of StellarCube, said: "This selection is an important opportunity to develop PainCube's global commercialization potential from an investor's perspective. Building on clinically grounded AI pain management technology, StellarCube will grow into a global medical AI platform that makes a real contribution to patient safety and clinical decision-making."